Summary
The anti-ischaemic properties of nimodipine 30 mg and 60 mg t.i.d. for 4 days has been tested in a double-blind, placebo-controlled, cross-over study based on the use of hyperventilation to reduce flow velocity in cerebral arteries. Whether the anti-ischaemic properties were due to a vasodilatator action on cerebral blood vessels or to an anti-ischaemic effect on cerebral neurons was studied. There was a slight cardiovascular effect, without any significant change in the EEG at rest. During standardized hyperventilation, there was no difference in the reduction in the blood flow velocity in the nimodipine and placebo groups (namely 56%, 56% and 59%). Both doses of nimodipine, however, significantly attenuated the hyperventilation-induced increase in slow EEG activity in the 1.5–6.0 Hz range. It is concluded that the anti-ischaemic properties of nimodipine are due to an effect on the central nervous system rather than to an effect on cerebral blood flow.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aaslid R, Markwalder TM, Nornes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocities in basal arteries. J Neurosurg 57: 769–774
Brouwers PJAM, Vriens EM, Musbach M, Wieneke GH, Huffelen AC van (1989) Transcranial pulsed Doppler measurements of blood flow velocity in the middle cerebral artery: reference values at rest and during hyperventilation in healthy children and adolescents in relation to age and sex. Ultrasound Med Biol 16: 1–8
Clark LC, Misraki GA, Fox RP (1958) Studies with chronically implanted polarographic electrodes. A.A.D.C. Techn. Rep. 57, 570, Fasc. Carpenter, Springfield, Ill, p 21
Engberding R, Bender F, Gülker H, Specker E, Molinski M (1984) Hemodynamic effects of the calcium channel-blocking agent nimodipine in normotensive and hypertensive subjects. Z Kardiol 73: 498–503
Fischhof PK, Wagner G, Littschauer L, Apacochez M, Hiersemenzel R, Röhmel J, Rüther E, Hoffmeister F, Schmage N (1989) Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Begener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York, pp 350–359
Forsman M, Fleischer JE, Milde JH, Steen PA, Michenfelder JD (1986) The effects of nimodipine on cerebral blood flow and metabolism. J Cerebral Blood Flow Metab 6: 763–767
Gelmers HJ, Gorter K, de Weerdt CJ, Wiezer HJA (1988) A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318: 203–207
Grotenhuis JA, Bettag W (1986) Prevention of symptomatic vasospasm after SAH by constant venous infusion of nimodipine. Neurol Res 8: 243–249
Harper AM, Craigen L, Kazda S (1981) Effect of the calciumantagonist nimodipine on cerebral blood flow and metabolism in the primate. J Cerebral Blood Flow Metabol 1: 349–356
Huber P, Handa J (1967) Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of the cerebral arteries — angiographic determination in man. Invest Radiol 2: 17–32
Itil TM, Güven F, Cora R, Hsu W, Polvan N, Ucok A, Sanseigne A, Ulett GA (1971) Quantitative pharmaco-electroencephalography using frequency analyzer and digital computer methods in early drug evaluations. In: Smith WL (ed) Drugs, development and brain functions. Thomas, Springfield, pp 145–166
Jan M, Buchheit F, Tremoulet M (1988) Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23: 154–157
Kazda S, Hoffmeister F, Garthoff B, Towart R (1979) Prevention of postischemic impaired reperfusion of the brain by nimodipine. Acta Neurol Scand 60 [Suppl 72]: 302–303
Kazda S, Knorr A, Towart R (1983) Common properties and differences between various calcium antagonists. Prog Pharmacol 5: 83–116
Kennealy JA, McLennan JE, Loudon RG, McLaurin RL (1980) Hyperventilation induced cerebral hypoxia. Am Rev Resp Dis 122: 407–412
Kety SS, Schmidt CF (1948) Effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 27: 484–492
Kraaier V, Huffelen AC van, Wieneke GH (1988) Changes in quantitative EEG and blood flow velocity due to standardized hyperventilation. A model for transient ischaemia in normal subjects. Electroencephalogr Clin Neurophysiol 70: 377–387
Kraaier V, Huffelen AC van, Wieneke GH (1989) The hyperventilation induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam. Eur J Clin Pharmacol 36: 605–611
Martinez-Villa E, Martinez-Lage JM, Guilen Llera F, Villanuova Eusa JA, Matias Guiu J, Bigorra Llosas J (1988) Nimodipine in acute stroke ischemic stroke. N Engl J Med 319: 249–251
Perouta SJ, Allen GC (1983) Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain. J Neurosurg 59: 933–937
Petruk KC, West M, Mohr G et al. (1988) Nimodipine treatment in poorgrade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68: 505–517
Philippon H, Grob R, Dagreou F et al. (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82: 110–114
Pickard JD, Murray GD, Illingworth R et al. (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298: 636–642
Rämsch KD, Graefe KH, Scherling D, Sommer J, Ziegler R (1986) Pharmacokinetics and metabolism of the calcium-blocking agents nifedipine, nitrendipine and nimodipine. Am J Nephrol 6 [Suppl 1]: 73–80
Steen PA, Newberg LA et al. (1983) Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cerebral Blood Flow Metab 3: 38–43
Steen PA, Newberg LA et al. (1984) Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cerebral Blood Flow Metabol 4: 82–87
Sugioka K, Davis DA (1960) Hyperventilation with oxygen, a possible cause of cerebral hypoxia. Anaesthesiology, 21: 135–143
Vriens EM, Kraaier V, Musbach M (1989) Hyperventilation induced changes of blood flow velocity in the middle cerebral artery in relation to age and sex. Transcranial pulsed Doppler ultra-sound measurements at rest and during hyperventilation. Ultrasound Med Biol 15: 1–8
Yamaguchi F, Meyer JS, Sakai F, Yamamoto M (1979) Normal human aging and cerebral vasoconstrictive response to hypocapnia. J Neurol Sci 44: 87–94
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kraaier, V., van Huffelen, A.C., Wieneke, G.H. et al. Nimodipine tested in a human model of cerebral ischaemia. Eur J Clin Pharmacol 40, 17–21 (1991). https://doi.org/10.1007/BF00315133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315133